{"id":"npc-12y-gel","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2372276","moleculeType":"Protein","molecularWeight":"1363.59"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"NPC-12Y gel is a regenerative medicine product that appears to work by delivering bioactive compounds to enhance wound healing processes. The exact molecular mechanism is proprietary to Nobelpharma, but topical gels in this class typically promote angiogenesis, collagen deposition, and epithelialization at the wound site.","oneSentence":"NPC-12Y is a topical gel formulation designed to promote wound healing and tissue regeneration through growth factor delivery.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:23:25.195Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Wound healing and tissue regeneration (specific indication under investigation in Phase 3)"}]},"trialDetails":[{"nctId":"NCT05495425","phase":"PHASE3","title":"Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2022-06-01","conditions":"Tuberous Sclerosis Complex","enrollment":43}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":334928,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NPC-12Y gel","genericName":"NPC-12Y gel","companyName":"Nobelpharma","companyId":"nobelpharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NPC-12Y is a topical gel formulation designed to promote wound healing and tissue regeneration through growth factor delivery. Used for Wound healing and tissue regeneration (specific indication under investigation in Phase 3).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}